MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance

E-ISSN： 1873-4286|22|7|933-939

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.7, 2016-02, pp. : 933-939

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-21: a therapeutic target for reversing drug resistance in cancer

By Hong Liu

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1073-1080

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA-34a: Role in Cancer and Cardiovascular Disease

Current Drug Targets, Vol. 15, Iss. 4, 2014-04 ,pp. : 361-373

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of microRNA‐375 and its target gene SMAD‐7 polymorphism on susceptibility of colorectal cancer

Journal Of Clinical Laboratory Analysis (Electronic), Vol. 32, Iss. 1, 2018-01 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

MicroRNA-34 Family, Mechanisms of Action in Cancer: A Review

Current Cancer Drug Targets, Vol. 14, Iss. 8, 2014-10 ,pp. : 737-751

Bentham Science Publishers

Access to resources Recommend Favorite

microRNA Biogenesis Pathway as a Therapeutic Target for Human Disease and Cancer

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 745-764

Bentham Science Publishers

Access to resources Recommend Favorite